Phosphorylation at tyrosine 114 of Proliferating Cell Nuclear Antigen (PCNA) is required for adipogenesis in response to high fat diet

Biochemical and Biophysical Research Communications

Volumn 430, Issue 1, 2013, Pages 43-48

  Lo, Yuan Hung ^a   Ho, Po Chun ^a   Chen, Min Shan ^a   Hugo, Eric ^a   Ben Jonathan, Nira ^a   Wang, Shao Chun ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Adipogenesis; PCNA; Proliferation; Tyrosine phosphorylation

Indexed keywords

CYCLINE; PHENYLALANINE; TYROSINE;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ALLELE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE MUTATION; LIPID DIET; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WILD TYPE;

ADIPOGENESIS; ADIPOSE TISSUE; ALLELES; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; BODY WEIGHT; CELL PROLIFERATION; DIET, HIGH-FAT; DNA REPLICATION; FEMALE; GENE KNOCK-IN TECHNIQUES; MICE; MICE, KNOCKOUT; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PHENYLALANINE; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; TYROSINE;

ANIMALIA; MUS;

EID: 84872423051     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.11.047     Document Type: Article

References (38)

1. Otto T.C., Lane M.D. Adipose development: from stem cell to adipocyte. Crit. Rev. Biochem. Mol. Biol. 2005, 40:229-242.
2. Hausman D.B., Di Girolamo M., Bartness T.J., Hausman G.J., Martin R.J. The biology of white adipocyte proliferation. Obes. Rev. 2001, 2:239-254.
3. Avram M.M., Avram A.S., James W.D. Subcutaneous fat in normal and diseased states 3 adipogenesis: from stem cell to fat cell. J. Am. Acad. Dermatol. 2007, 56:472-492.
4. Hirsch J., Batchelor B. Adipose tissue cellularity in human obesity. Clin. Endocrinol. Metab. 1976, 5:299-311.
5. Hager A., Sjostrm L., Arvidsson B., Bjorntorp P., Smith U. Body fat and adipose tissue cellularity in infants: a longitudinal study. Metabolism 1977, 26:607-614.
6. Arner E., Westermark P.O., Spalding K.L., Britton T., Ryden M., Frisen J., Bernard S., Arner P. Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 2010, 59:105-109.
7. Spalding K.L., Arner E., Westermark P.O., Bernard S., Buchholz B.A., Bergmann O., Blomqvist L., Hoffstedt J., Naslund E., Britton T., Concha H., Hassan M., Ryden M., Frisen J., Arner P. Dynamics of fat cell turnover in humans. Nature 2008, 453:783-787.
8. Rosen E.D., MacDougald O.A. Adipocyte differentiation from the inside out. Natl. Rev. Mol. Cell Biol. 2006, 7:885-896.
9. Cornelius P., MacDougald O.A., Lane M.D. Regulation of adipocyte development. Annu. Rev. Nutr. 1994, 14:99-129.
10. MacDougald O.A., Lane M.D. Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 1995, 64:345-373.
11. MacDougald O.A., Mandrup S. Adipogenesis: forces that tip the scales. Trends Endocrinol. Metab. 2002, 13:5-11.
12. Tang Q.Q., Otto T.C., Lane M.D. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc. Natl. Acad. Sci. USA 2003, 100:44-49.
13. Moldovan G.L., Pfander B., Jentsch S. PCNA the maestro of the replication fork. Cell 2007, 129:665-679.
14. Roa S., Avdievich E., Peled J.U., MacCarthy T., Werling U., Kuang F.L., Kan R., Zhao C., Bergman A., Cohen P.E., Edelmann W., Scharff M.D. Ubiquitylated PCNA plays a role in somatic hypermutation and class-switch recombination and is required for meiotic progression. Proc. Natl. Acad. Sci. 2008, 105:16248-16253.
15. Maga G., Hubscher U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J. Cell Sci. 2003, 116:3051-3060.
16. Paunesku T., Mittal S., Protic M., Oryhon J., Korolev S.V., Joachimiak A., Woloschak G.E. Proliferating cell nuclear antigen (PCNA): ringmaster of the genome. Int. J. Radiat. Biol. 2001, 77:1007-1021.
17. Kelman Z. PCNA: structure functions and interactions. Oncogene 1997, 14:629-640.
18. Komatsu K., Wharton W., Hang H., Wu C., Singh S., Lieberman H.B., Pledger W.J., Wang H.G. PCNA interacts with hHus1/hRad9 in response to DNA damage and replication inhibition. Oncogene 2000, 19:5291-5297.
19. Krishna T.S., Kong X.P., Gary S., Burgers P.M., Kuriyan J. Crystal structure of the eukaryotic DNA polymerase processivity factor PCNA. Cell 1994, 79:1233-1243.
20. Jonsson Z.O., Podust V.N., Podust L.M., Hubscher U. Tyrosine 114 is essential for the trimeric structure and the functional activities of human proliferating cell nuclear antigen. Embo J. 1995, 14:5745-5751.
21. Tang Q.-Q., Otto T.C., Lane M.D. CCAAT/enhancer-binding protein b is required for mitotic clonal expansion during adipogenesis. Proc. Natl. Acad. Sci. USA 2003, 100:850-855.
22. Xu J. Preparation Culture and Immortalization of Mouse Embryonic Fibroblasts in Current Protocols in Molecular Biology 2001, John Wiley & Sons, Inc., pp. 28.21.21-28.21.27.
23. Tinsley F.C., Taicher G.Z., Heiman M.L. Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis. Obes. Res. 2004, 12:150-160.
24. Wang S.-C., Nakajima Y., Yu Y.-L., Xia W., Chen C.-T., Yang C.-C., McIntush E.W., Li L.-Y., Hawke D.H., Kobayashi R., Hung M.-C. Tyrosine phosphorylation controls PCNA function through protein stability. Nat. Cell Biol. 2006, 8:1359-1368.
25. Zhao H., Lo Y.-H., Ma L., Waltz S.E., Gray J.K., Hung M.-C., Wang S.-C. Targeting tyrosine phosphorylation of PCNA inhibits prostate cancer growth. Mol. Cancer Ther. 2011, 10:29-36.
26. Zhao H., Ho P.-C., Lo Y.-H., Espejo A., Bedford M.T., Hung M.-C., Wang S.-C. Interaction of proliferation cell nuclear antigen (PCNA) with c-Abl in cell proliferation and response to DNA damages in breast cancer. PLoS ONE 2012, 7:e29416.
27. Auld C.A., Morrison R.F. Evidence for cytosolic p27(Kip1) ubiquitylation and degradation during adipocyte hyperplasia. Obesity (Silver Spring) 2006, 14:2136-2144.
28. Morrison R.F., Farmer S.R. Role of PPAR gamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis. J. Biol. Chem. 1999, 274:17088-17097.
29. Naaz A., Holsberger D.R., Iwamoto G.A., Nelson A., Kiyokawa H., Cooke P.S. Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity. FASEB J. 2004, 18:1925-1927.
30. Lin J., Della-Fera M.A., Li C., Page K., Choi Y.H., Hartzell D.L., Baile C.A. P27 knockout mice reduced myostatin in muscle and altered adipogenesis. Biochem. Biophys. Res. Commun. 2003, 300:938-942.
31. Inoue N., Yahagi N., Yamamoto T., Ishikawa M., Watanabe K., Matsuzaka T., Nakagawa Y., Takeuchi Y., Kobayashi K., Takahashi A., Suzuki H., Hasty A.H., Toyoshima H., Yamada N., Shimano H. Cyclin-dependent kinase inhibitor p21WAF1/CIP1 is involved in adipocyte differentiation and hypertrophy linking to obesity and insulin resistance. J. Biol. Chem. 2008, 283:21220-21229.
32. Besson A., Dowdy S.F., Roberts J.M. CDK inhibitors: cell cycle regulators and beyond. Dev. Cell 2008, 14:159-169.
33. Abella A., Dubus P., Malumbres M., Rane S.G., Kiyokawa H., Sicard A., Vignon F., Langin D., Barbacid M., Fajas L. Cdk4 promotes adipogenesis through PPAR gamma activation. Cell. Metab. 2005, 2:239-249.
34. Aguilar V., Annicotte J.-S., Escote X., Vendrell J., Langin D., Fajas L. Cyclin G2 regulates adipogenesis through PPARγ coactivation. Endocrinology 2010, 151:5247-5254.
35. Sarruf D.A., Iankova I., Abella A., Assou S., Miard S., Fajas L. Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor γ. Mol. Cell. Biol. 2005, 25:9985-9995.
36. Li X., Kim J.W., Gronborg M., Urlaub H., Lane M.D., Tang Q.Q. Role of cdk2 in the sequential phosphorylation/activation of C/EBP beta during adipocyte differentiation. Proc. Natl. Acad. Sci. USA 2007, 104:11597-11602.
37. Prins J.B., O'Rahilly S. Regulation of adipose cell number in man. Clin. Sci. (Lond) 1997, 92:3-11.
38. Bjorntorp P. Effects of age sex and clinical conditions on adipose tissue cellularity in man. Metabolism 1974, 23:1091-1102.